A - Agilent Technologies Inc.
Close
142.92
0.390 0.273%
Share volume: 1,570,668
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$142.53
0.39
0.27%
View ratios
| Fiscal Date | 2022-07-31 | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 | 2024-04-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-09-01 | 2022-12-21 | 2023-03-03 | 2023-05-26 | 2023-08-31 | 2023-12-20 | 2024-03-05 | 2024-06-03 | |
| Assets | |||||||||
| Total Assets | 10.484 B | 10.532 B | 10.919 B | 10.792 B | 10.675 B | 10.763 B | 10.948 B | 10.856 B | |
| Current Assets | 3.690 B | 3.778 B | 4.078 B | 3.949 B | 4.030 B | 4.186 B | 4.338 B | 4.203 B | |
| Inventories | 1.010 B | 1.038 B | 1.111 B | 1.103 B | 1.072 B | 1.031 B | 1.033 B | 1.000 B | |
| Other Current Assets | 258.000 M | 282.000 M | 258.000 M | 270.000 M | 290.000 M | 274.000 M | 262.000 M | 283.000 M | |
| Short Term Investments | 258.000 M | 282.000 M | 258.000 M | 270.000 M | 290.000 M | 274.000 M | 262.000 M | 283.000 M | |
| Total Receivables | 1.345 B | 1.405 B | 1.459 B | 1.401 B | 1.339 B | 1.291 B | 1.295 B | 1.249 B | |
| Current Cash | 1.077 B | 1.053 B | 1.250 B | 1.175 B | 1.329 B | 1.590 B | 1.748 B | 1.671 B | |
| Total Non-current Assets | 6.794 B | 6.754 B | 6.841 B | 6.843 B | 6.645 B | 6.577 B | 6.610 B | 6.653 B | |
| Property Plant Equipment | 1.054 B | 1.100 B | 1.147 B | 1.184 B | 1.211 B | 1.270 B | 1.314 B | 1.371 B | |
| Other Assets | 749.000 M | 686.000 M | 713.000 M | 695.000 M | 758.000 M | 708.000 M | 716.000 M | 725.000 M | |
| Intangible Assets | 849.000 M | 821.000 M | 810.000 M | 798.000 M | 502.000 M | 475.000 M | 443.000 M | 417.000 M | |
| Goodwill | 3.948 B | 3.952 B | 3.983 B | 3.980 B | 3.984 B | 3.960 B | 3.967 B | 3.963 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.484 B | 10.532 B | 10.919 B | 10.792 B | 10.675 B | 10.763 B | 10.948 B | 10.856 B | |
| Total liabilities | 5.393 B | 5.227 B | 5.310 B | 5.011 B | 5.117 B | 4.918 B | 4.760 B | 4.642 B | |
| Total current liabilities | 1.902 B | 1.861 B | 1.936 B | 1.666 B | 1.760 B | 1.603 B | 1.617 B | 1.958 B | |
| Accounts Payable | 558.000 M | 580.000 M | 540.000 M | 479.000 M | 452.000 M | 418.000 M | 488.000 M | 461.000 M | |
| Other liabilities | 759.000 M | 633.000 M | 641.000 M | 612.000 M | 623.000 M | 580.000 M | 588.000 M | 548.000 M | |
| Current long term debt | 180.000 M | 36.000 M | 238.000 M | 0.000 | 55.000 M | 0.000 | 0.000 | 420.000 M | |
| Long term debt | 2.732 B | 2.733 B | 2.733 B | 2.733 B | 2.734 B | 2.735 B | 2.555 B | 2.136 B | |
| Other liabilities | 759.000 M | 633.000 M | 641.000 M | 612.000 M | 623.000 M | 580.000 M | 588.000 M | 548.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.091 B | 5.305 B | 5.609 B | 5.781 B | 5.558 B | 5.845 B | 6.188 B | 6.214 B | |
| Common stock | 298.000 M | 298.000 M | 296.000 M | 296.000 M | 294.000 M | 290.000 M | 293.000 M | 293.000 M | |
| Retained earnings | 139.000 M | 324.000 M | 541.000 M | 700.000 M | 444.000 M | 782.000 M | 1.061 B | 1.090 B |